study question: Is the quality of the human embryos generated by twinning in vitro comparable to the quality of the embryos created by fertilization?
Introduction
Pregnancy from in vitro generated monozygotic twins by embryo splitting or twinning leads to the live birth of healthy animals. Among large animals, successful twinning has been reported for sheep (Willadsen, 1979) , cattle (Seike et al., 1991 (Seike et al., , 1989 Johnson et al., 1995) , goats (Tsunoda et al, 1985) , pigs (Reichelt and Niemann, 1994) and horses (Allen and Pashen, 1984) . Similar strategies, however, have been less successful in primates. In one study, a total of 368 embryos created by splitting of 8-cell rhesus monkey embryos to produce sets of identical quadruplets, each consisting of two blastomeres, resulted in four pregnancies and only one live birth after 13 embryo transfers (Chan et al., 2000) , whereas in another study on rhesus monkeys, embryo transfer of identical twins, created by either blastomere separation of 2-to 4-cell embryos or blastocyst bisection, resulted in a 33% clinical pregnancy rate with two twin pregnancies initiated, although no live births occurred (Mitalipov et al., 2002 ).
Hall and Stillman described the first human embryo splitting at a joint meeting of the American Fertility Society and the Canadian Fertility and Andrology Society in October 1993 (Hall et al., 1993) . They separated blastomeres of 17 2-to 8-cell embryos and grew them up to 32-cell divisions. They used polyspermic embryos that would not survive and that would be routinely discarded. It later came to light that the work lacked Institutional Review Board approval and the researchers were disciplined and instructed to destroy their data (Fackelmann, 1994; Macklin, 1995) . The Ethics Committee of the American Society for Reproductive Medicine subsequently developed a statement on embryo splitting for infertility treatment, which was accepted by the Board of Directors in December 1995 (The Ethics Committee of the American Society for Reproductive Medicine, 2004). They did not see a major ethical objection to placing two or more artificially created embryos with the same genome in the uterus with the hope of producing a single pregnancy. Regulatory bodies in other countries have not shared this view. For example, in the UK, The Human Reproductive Cloning Act (2001, Chapter 23) makes it a criminal offence, punishable by up to 10 years in prison and/or an unlimited fine, to place into a woman an embryo created by any means other than by fertilization and the 6th Human Fertilisation and Embryology Authority (HFEA) Code of Practice, paragraph 8.9 (ii) makes it clear that clinics are expected not to produce embryos for treatment by embryo splitting (The Human Fertilisation and Embryology Authority, 2003) .
Recent reports have suggested that the splitting of human embryos might result in viable, morphologically adequate blastocysts (Van de Velde et al., 2008; Illmensee et al., 2010) , although the qualitative analyses of the embryos created in such a way have been very limited. Whereas one group has shown that the blastomeres of 4-cell embryos have sufficient plasticity to develop into blastocysts (Van de Velde et al., 2008) , the data from the other group has suggested that the single blastomeres from 8-cell embryos would develop into overall better quality blastocysts than the single blastomere from the earlier stages (Illmensee et al., 2010) .
The scarcity of human embryos donated for research prompted us to investigate the possibility of using embryo splitting technology to generate embryos for purposes such as validating new culture media, training embryologists and developing new technologies. The use of twinned embryos would avoid genetic background bias that can lead to misinterpretation of data and increases the number of embryos needed for validation. However, the quality of the human embryos generated by twinning in vitro would need to be comparable to the quality of those created by fertilization. To investigate the suitability of such embryos as a research tool, we analysed morphokinetics and developmental competence of 176 twin embryos created by splitting of 88 human embryos from either the early (2-5 blastomeres, n ¼ 43) or late (6 -10 blastomeres, n ¼ 45) cleavage stages.
Materials and Methods
The work described here was done under licence from the UK Human Fertilisation and Embryology Authority (research licence numbers: R0075 and R0133) and also has local ethical approval (UK National Health Service Research Ethics Committee Reference: 06/Q0702/90). Informed consent was obtained from all subjects and the experiments conformed to the principles set out in the WMA Declaration of Helsinki and the NIH Belmont Report. No financial inducements were offered for donation.
Human embryo culture
All embryos used in the study had been cryopreserved using the slow freezing method. The embryos were thawed using Quinn's Advantage Thaw Kit (Sage) according to the manufacturer's instructions. Before they were manipulated, the embryos were cultured for at least 4 h in 40-ml microdrops of Quinn's Cleavage Medium supplemented with 10% Quinn's Advantage TM Serum Protein Substitute (SPS; Sage) under mineral oil (Sage) in a humidified atmosphere at 378C, in 6% CO 2 and 5% O 2 . Prior to biopsy, to allow mild dissociation of blastomeres from one another, the embryos were incubated in 20 ml of Quinn's Advantage w Ca/Mg-Free Medium with HEPES (Sage) supplemented with 10% SPS and overlayed with oil for 3 min at 378C. The biopsy procedure was carried out on the heated stage of a Nikon IX-70 microscope equipped with micromanipulation tools (Research Instruments) at 20% O 2 atmosphere. We opened a 30-to 40-mm hole in the zona pellucida with a fixed position laser system Saturn 3 TM (Research Instruments) utilizing a laser pulse length of 750 ms. Half of the blastomeres were aspirated and removed from a donor embryo and placed in an empty zona pellucida, previously prepared from clinically unsuitable oocytes or embryos (Fig. 1, Supplementary data, Fig. S1 and Movie S1).
After blastomere transfer, the donor embryos (Twins A) and recipient embryos (Twins B) were transferred into a previously prepared embryo slide dish containing pre-equilibrated Quinn's blastocyst Medium supplemented with 10% SPS in 6% CO 2 and covered with mineral oil. Twins A were placed in the EmbryoSlide w wells with odd numbers (1, 3, 5, 7, 9 and 11) and the wells with even number (2, 4, 6, 8 and 12) were used to culture the Twins B. During the splitting procedure, the embryoslide was initially placed in Heraeus incubator until the procedure was completed; 1 h was required to split six embryos. The twin embryos were cultured in EmbryoScope w , an incubator with a time-lapse system (Fertilitech). Images were recorded automatically every 20 min. Registered events and their definitions are listed in Fig. 2 . Time-lapse movies were processed for morphokinetics data with EmbryoViewer w software (Supplementary data, Movie S2).
Immunostaining
Immunostaining was performed as described (Niakan and Eggan, 2013) . Primary antibodies were rabbit polyclonal anti-YAP1 (Cell Signaling) and anti-GATA2 (Santa Cruz Biotechnology), goat polyclonal anti-NANOG (R&D, USA), mouse monoclonal anti CDX2 (BioGenex). Secondary antibodies were purchased from Life Technologies. Nuclei are visualised with 4 ′ ,6-diamidino-2-phenylindole in mounting medium (DAPI; Vector). Confocal microscopy was carried out using TCS SP5 microscope. Images were processed using ImageJ64 and Adobe Photoshop CC 2014 software.
Statistical analysis
The statistical analyses were performed by GenoSplice. Briefly, for comparison of proportion we used x 2 test when applicable (expected values ≥5), 
Results
Blastomere donor and blastomere recipient twins have similar developmental potential A total of 88 cleavage stage embryos were divided into two groups: Group 1 (n ¼ 43), comprising early cleavage stage, consisting of embryos with 2-5 blastomeres and Group 2 (n ¼ 45), comprising late cleavage stage, consisting of embryos with 6-10 blastomeres. Half of the blastomeres in each embryo were biopsied and placed into an empty zona pellucida ( Fig. 1 and Supplementary data, Movie S1) prepared in advance by removing the cellular content from immature oocytes or degraded, clinically unsuitable embryos (Supplementary data, Fig. S1 ). The blastomere donor embryos were dubbed Twin A and the blastomere recipients were dubbed Twin B. Resulting twin embryos were cultured in an incubator with a built-in microscope and camera for morphokinetic studies (Supplementary data, Movie S2). For controls, we used morphokinetic data from normal embryos that had been subjected to laser ablation of the zona pellucida on Day 3, then were cultured to Days 5-6 and used for single embryo transfer, resulting in clinical pregnancy (n ¼ 42). Events annotated in time-lapse analyses are illustrated in Fig. 2A , whereas raw data are in Supplementary data, Table SI. Twins from Group 2 developed, in general, into more viable and better quality blastocysts compared with embryos from Group 1; 26 expanding blastocysts (EBs) out of 86 twin embryos (30.23%) in Group 1 versus 38 EBs out of 90 twin embryos (42.22%) in Group 2. Although it appeared that overall Twins B developed to a later stage than Twins A, the only significant difference was in the number of embryos reaching blastocyst stage (B) in Group 1: 13 of Twin A versus 23 of Twin B embryos (30.23 versus 53.49%; P ¼ 0.049: Fig. 2B ). Next, we compared the developmental potential of Twins A and B originating from 1 (n ¼ 4), 2 (n ¼ 21), 3 (n ¼ 11) and 4 (n ¼ 24) blastomeres that reached the stage of EB, regardless of the group of origin. Whereas Twins A and B performed similarly (Fig. 2C) , the embryos created from higher number of blastomeres (3 and 4) seemed to develop better than their counterparts created from one or two blastomeres (Fig. 2D ).
Temporal control of human preimplantation development
Next, we compared the duration of critical landmark events in embryo development: compaction (9+ to M), initiation of cavitation (M -C), blastocyst formation (C-B) and blastocyst expansion (B -EB) in embryos that reached the stage of EB (Fig. 3) . Although the difference was less pronounced between control embryos and twins in Group 1 than in Group 2, when pooled together the difference was significant throughout all stages and especially high for blastocyst formation (P ¼ 0.006 for Twins A and P ≤ 0.001 for Twins B) and blastocyst expansion (P ≤ 0.001 for both Twins A and B) (Fig. 3A) . Comparisons of Twins A and B originating from 1, 2, 3 and 4 blastomeres did not reveal marked Figure 2 Successful development of twin embryos into expanding blastocyst is associated with the starting number of blastomeres. (A) Developmental stages used for morphokinetics analyses: 9+, more than nine blastomeres; M, morula/fully compacted embryo; C, initiation of cavitation; B, blastocyst; EB, expanding blastocyst. (B) Both twins, A and B, originated from the late cleavage parental embryos (Group 2, 6-10 blastomeres) had a higher chance of progressing in development than twins originated from the early cleavage parental embryos (Group 1, 2 -5 blastomeres). In both groups, Twins B show a trend towards better development than Twins A. The difference was, however, statistically significant only at the blastocyst stage (B). (C) Twins originating from a higher number of blastomeres have a higher chance of develop further. Twins B show a trend towards better development than Twins A, regardless of starting number of blastomeres. (D) The proportion of the embryos reaching each of developmental stage used for morphokinetics analyses differs within the group depending on the number of starting blastomeres, although there is no overall difference between Groups 1 and 2.
Developmental clock and human embryo splitting and other stages revealed that the differences between twins and control embryos are restricted to the earlier stages: 9+ till compaction (M) and 9+ till cavitation (F). Data from the embryos created from five blastomeres could not be used for statistical purposes due to low number of replicates. differences in their developmental dynamics, although some significance was noted between twins at the compaction and expansion stages ( Fig. 3B and C) .
However, if we approach the analysis of developmental dynamics in a somewhat different way, the differences between twins and control embryos appear to be restricted to the earlier stages (Fig. 3D-F) . Comparison of the duration from 9+ stage to blastocyst expansion (9+ to EB) was similar between twins and control embryos. However, the duration from 9+ stage to compaction (9+ to M) and from 9+ to cavitation (9+ to C) was significantly shorter in twins than in control embryos, especially in twins in Group 2, suggesting a kind of 'compensation' for lower cell number (Fig. 3D) . Except in the time needed to reach the morula stage, we found overall no marked differences between Twins A and B, regardless of the number of blastomeres used for their creation (Fig. 3E and F) .
Since all twin embryos (n ¼ 64) reached the EB stage in a similar time period to the control embryos (n ¼ 42) (average times 35.82 and. 32.69 h, respectively), in spite of the significant differences found in the duration of certain stages of development and different number of blastomeres used for their creation, the data suggest that preimplantation development occurs with a strict temporal precision.
Indeed, an average duration from creation to 9+ stage in control embryos was 83.54 h (n ¼ 42) and for the early cleavage stage group (Group 1, 2-5 blastomeres), 48.37 h for Twins A (n ¼ 9) and 46.02 for Twins B (n ¼ 17). Late cleavage stage embryos (Group 2, 5-10 blastomeres) needed nearly half of this time, an average of 20.93 h for Twins A (n ¼ 21) and 20.60 h for Twins B (n ¼ 17) (Fig. 4A) . The embryos used as experimental groups were frozen at different IVF centres over a span of several years and we do not know precisely how many hours they needed in the culture to develop from the 2PN stage till 2-5 cells (Group 1) or 6 -10 cells (Group 2). However, we can safely estimate that embryos in the Group 2 were, in general, twice as long in the culture as embryos in the Group 1. If approximate time for the embryos from Group 1 was ≈30 h and for the embryos from Group 2 was double, ≈60 h, the total time needed from embryos to develop from pronuclear (2PN) stage to EB was quite similar to the control embryos (Fig. 4B) . The majority of the twins created from either one (n ¼ 4) or two blastomeres (n ¼ 21) had originated from the early cleavage stage embryos and, accordingly, needed twice as much time to reach the 9+ stage (Fig. 4C) .
Size of the twin blastocyst is proportionate to the number of blastomeres used for the creation of the embryo As reported previously, the twin blastocysts were smaller than control embryos ( Van de Velde et al., 2008) . A significant difference in size was detected regardless of whether they were Twins A or B or Group 1 or 2 twin blastocysts ( Fig. 5A and B) . If a temporal control of development Figure 4 Temporal control of development from pronuclear (2PN) to blastocyst expansion. (A) The average duration from creation to the 9+ stage in control embryos was nearly twice as long as that in embryos from Group 1 and 4-fold longer than that in Group 2. (B) Estimate of time passed from 2PN until blastocyst expansion. We do not know precisely how many hours the embryos needed in the culture to develop from the 2PN stage to 2 -5 cells (Group 1) or 6 -10 cells (Group 2), although we can predict that embryos in Group 2 took, in general, twice as long in the culture as embryos in Group 1. (C) Twins created from either one (n ¼ 4) or two blastomeres (n ¼ 21) had originated from the early cleavage stage embryos and, accordingly, needed twice as much time to reach the 9+ stage as twins created from three or more blastomeres. All measurements are in hours. n, number of replicates.
Developmental clock and human embryo splitting is strictly enforced, as our data suggested, the number of cell divisions that the biopsied blastomeres can do before onset of the blastulation and lineage commitment would be limited by their age. Indeed, the diameter of twin blastocysts was proportionate with number of starting blastomeres (Fig. 5C ). An average diameter for a twin embryo originated from a single or two blastomeres was 86.93 mm (n ¼ 7) and 101.91 mm (n ¼ 28), respectively, whereas twins starting from four blastomeres were on average 102.25 mm (n ¼ 38) and those starting from five blastomeres were 106.83 mm (n ¼ 3). The average diameter for control embryos was 120.87 mm (n ¼ 42).
Poor ICM quality and developmental delay of the twin embryos
In spite of the higher yield and larger size of the blastocysts created from the blastomeres of late cleavage embryo (Group 2), only 36.46% (15 out of 38) had a distinguishable ICM. In Group 1, however, 52% (13 out of 26) of the blastocysts had distinguishable ICM. Three ICMs in the Group 1 and only one in the Group 2 were Grade B; all others were Grade C (Stephenson et al., 2006) .
The first cell fate decision at the late morula stage involves space segregation. The outer cells give rise to the trophectoderm (TE), the first extraembryonic lineage, whereas the ICM will retain pluripotency (Johnson and Ziomek, 1981) . Following compaction on Day 4 and cavitation on Day 5, the normal human in vitro fertilized and cultured embryo would develop by Day 6 into expanded blastocysts with clearly distinguishable TE and ICM. We assessed the Day 5 (n ¼ 5 pairs) and Day 6 twin blastocysts (n ¼ 5 pairs) for markers of TE (CDX2 and GATA2) and ICM (NANOG). Images in Fig. 6 are the representative pairs of each cohort. On Day 5, although we could not discriminate ICM in either Twin A or B of the pair presented, we could detect a single NANOG only-positive cell in Twin A (Fig. 6 and Supplementary data, Fig. S2 ), indicating that the potential for ICM formation is present and that ICM development is there and might be just lagging behind. All other NANOG-positive cells in both twins also expressed TE markers. On Day 6, when both twin blastocysts start expanding, the ICM was visible in Twin B, but not in Twin A of the pair presented. Immunostaining revealed NANOG only positive cells in both twins, consistent with a developmental delay. Twin B seemed to have two independent ICMs developing de novo.
Attempts to culture the twin blastocysts beyond Day 6 were unsuccessful. The embryos did not survive in the blastocyst media beyond Day 6/7. The media specifically developed for culturing mouse blastocysts beyond the implantation stages (Bedzhov et al., 2014) did not fully support culture of human blastocysts in our hands and it may require protocol modifications before it could be used in the human system (Y. Dajani and D. Ilic, Unpublished observations). Our team has extensive experience in derivation of human embryonic stem cell (hESC) lines from intact blastocysts Stephenson et al., 2012; Jacquet et al., 2013) as well as from single blastomeres (Ilic et al., 2009; Giritharan et al., 2011) . However, none of the twin embryos (n ¼ 5 pairs) gave rise to either hESC lines or initial outgrowth under standard conditions that in our hands usually has a success of 30-50%, even though all of the blastocysts had distinguishable ICM-like structures. The diameter of twin blastocyst stage embryos generated from 1 (n ¼ 16), 2 (n ¼ 68), 3 (n ¼ 43), 4 (n ¼ 54) and 5 (n ¼ 4) blastomeres was significantly different from control embryos (1: FC ≈ 1.39 and P-value ≤0.001; 1: FC ≈ 1.19 and P-value ≤0.001; 3: FC ≈ 1.21 and P-value ≤0.001; 4: FC ≈ 1.18 and P-value ≤0.001; 5: FC ≈ 1.13 and P-value ≤0.05). Statistical tests could not be performed on twin embryos generated from six blastomeres due to sample size (n ¼ 1). Statistical analysis: Student's test. Alpha risk: 5%. FC, average fold-change;; *P-value ≤0.5; ***P-value ≤0.001. Figure 6 Immunostaining of lineage markers in control and twin blastocysts. In contrast to non-manipulated Day 5 blastocysts, which have NANOG localized in inner cell mass (ICM), and CDX2 and GATA2 in trophectoderm (TE), the Day 5 blastocysts derived from split embryos contained cells with a dual expression of TE and ICM markers and had poorly developed or indistinguishable ICM. Arrowheads: cells expressing all three markers. Arrows: cells expressing strongly ICM marker NANOG and TE marker CDX2. Asterisk: a cell with strong NANOG and weak CDX2 expression.
Developmental clock and human embryo splitting

Discussion
The limited number of embryo splitting studies in primates (Chan et al., 2000; Mitalipov et al., 2002) and humans (Hall et al., 1993; van de Velde et al., 2008; Illmensee et al., 2010) has left open the question of developmental competence of split human embryos. The morphokinetic and lineage marker expression analyses presented here have now suggested that the earliest stages of human development are under strict temporal control; i.e. regardless of the number of blastomeres used to create split embryos, they all take the same length of time to reach the EB stage, with blastocyst size correlating with the starting number of blastomeres. The data also show that the cell-cell interaction between cleavage stage blastomeres is not essential for the development of embryos into blastocysts; there was no any overall statistically significant difference between the twin embryos in which blastomeres were not perturbed (donors or Twins A) and those in which blastomere were transferred one by one from the donor embryo (recipients or Twins B). A further observation of interest is that there was discordance of blastulation morphokinetics and lineage commitment in the twin embryos; ICM formation was delayed and the first cells expressing NANOG without co-expression of TE markers CDX2 or GATA2 were rarely detected before Day 6, when the blastocysts were already undergoing expansion.
Previously, separation of blastomeres from 2-cell mouse embryos has produced monozygotic twins, whereas individual blastomeres of 4-cell stage embryos have resulted in developmentally incompetent conceptuses, which have died following implantation (Tarkowski and Wroblewska, 1967; Rossant, 1976) . Spatial and temporal analyses of the mouse embryos have suggested the existence of a 'developmental clock' (Morris et al., 2012) . In this study, since the processes of cell compaction, cavitation and lineage commitment were occurring at the same time in split and control non-manipulated embryos, the cellularity and size of the blastocyst was in a correlation with the number and 'age' of the blastomeres from which it was created. We cannot exclude the possibility that in the manipulated human embryos from frozen cycles, asynchrony in blastomere differentiation/pluripotency might result in preferential contribution of the advanced blastomeres to the embryo, loss of earlier blastomeres and de facto contribution of only a limited number of blastomeres to the embryo (Schramm and Paprocki, 2004) . Although in such a case, we would likely notice more often a discrepancy in development between Twin A and B from the same donor embryo.
In order to be developmentally fully competent, the mouse embryos have to develop an epiblast with a minimum of four pluripotent cells before implantation, and single blastomeres from 4-cell mouse embryos have not been capable of this. However, the existence of a 'developmental clock' and the need for an epiblast of a certain size in higher animals, including humans, has been questionable: identical calves have been produced from single blastomeres of 4-cell embryos (Johnson et al., 1995) and a child has been born following transfer of a 4-cell human embryo, where only a single blastomere had survived thawing (Veiga et al., 1987) . A report on splitting human 4-cell embryos into single blastomeres described small blastocysts (van de Velde et al., 2008) with NANOG-positive cells. Furthermore, hESC lines have been derived from single blastomeres of 4-as well as 8-cell embryos Chung et al., 2008; Geens et al., 2009; Ilic et al., 2009) . However, ESC lines have been generated also from a single blastomere of 2-, 4-and 8-cell mouse embryos Lorthongpanich et al., 2008) , suggesting that developmental competence and plasticity of the embryo cannot be judged by the ability to produce pluripotent stem cell lines.
All embryos used in our research project were cryopreserved at either 2PN or cleavage stage. The number of hours that these embryos were in culture before freezing could only be estimated and could have varied considerably for two embryos of a similar stage. Since there were, to our knowledge, no previous reports of strict temporal control of preimplantation development in humans, we decided our splitting strategy following the approach of Tsunoda and McLare (1983) . This group could overcome the developmental clock limitation by mechanically dividing blastomeres of 8-cell mouse embryo into two equal groups. In spite of that, our morphokinetic results presented here strongly suggest that such a developmental clock is also in place during human preimplantation development.
Work in the mouse system has demonstrated the importance of continuous cell-cell interaction in the blastomere fate specification as the blastomeres are likely to have re-established interactions after transfer into the recipient zonae (Johnson and Ziomek, 1981; Lorthongpanich et al., 2012) . In contrast to a pre-patterning model ), which proposes that the ICM-and TE-lineages are predetermined by the asymmetrical localization of molecular determinants in the oocyte, inside-out (Tarkowski and Wroblewska, 1967) and cell polarity models (Johnson and Ziomek, 1981) favour position-dependent decision-making. Our data from twin embryos suggest that the lineage determination in human embryos works through either the inside-out or the cell polarity model. In case of the pre-patterning model, because the number of the blastomeres used for creating twin embryos would not matter, one would expect more of the embryos with better quality ICMs. Recent studies have demonstrated that the Hippo pathway is translating positional information to lineage specification, acting mainly through downstream effectors YAP1 and TEAD1-4 (reviewed in Lorthongpanich and Issaragrisil, 2015) . Nuclear localization of YAP1 in twin embryos was for the first time detected in a subset of cells in the early morula, whereas on Day 6 it was overlapping with CDX2 expression as in the control blastocysts, suggesting that this mechanism might be conserved in human embryos too (Supplementary data, Fig. S3 ).
The first fate decision, segregation to ICM and TE, becomes evident at 9+ or compaction/morula stages, when asymmetric cell division leads to one daughter cell remaining outside and the second pushed internally (Bruce and Zernicka-Goetz, 2010; Lorthongpanich et al., 2012) . The decision is not, however, final. For some time, the outer cells from morula and early blastocyst retain their plasticity. They express both pluripotency markers POU5F1 (OCT4), SOX2 and SALL4 as well as TE markers HLA-G and KRT18, but not CDX2 Chen et al., 2009; Verloes et al., 2011) . NANOG has been detected in polar TE of an early blastocyst . Furthermore, isolated and reaggregated TE cells from full human blastocysts are able to develop into blastocysts with ICM cells expressing the pluripotency marker NANOG (De Paepe et al., 2013) . On Day 5, in our twin embryos, NANOG was expressed almost ubiquitously, with NANOGpositive cells also positive for TE markers CDX2 and GATA2. To eliminate the possibility of false-positive NANOG signals in our immunostaining studies, in most experiments, we processed twin and control embryos in the same drop; they were easily distinguishable due to the difference in their size. On Day 6, the number of TE cells that co-expressed NANOG with CDX2 and GATA2 started to dwindle, although they still represented the majority of cells in TE, whereas only one to four cells lost CDX2 and GATA2 expression, indicating initial formation of ICM. On Day 6, in twins with larger ICM, we also detected SOX17, a marker of parietal endoderm (Supplementary data, Fig. S4 ). Molecular events leading to the first and second fate commitment appeared to be in place, though somewhat lagging behind the events in normal blastocysts obtained through fertilization. Regardless, on Day 6 in all twin embryos if ICM was present at all, it was small and of poor quality, suggesting that the epiblast may have insufficient cells to continue the development of the conceptus post-implantation (Balbach et al., 2010; Morris et al., 2012) . This may explain the poor results of twinning experiments in primates (Chan et al., 2000; Mitalipov et al., 2002) .
Taken together, our data suggest that the 'developmental clock' is also driving human early development, although the precise mechanism remains to be established. The timing set by the developmental clock may interfere with lineage commitments and molecular events in twin embryos created with blastomere transfer, impeding their developmental competence and therefore making them unsuitable as research embryos for, e.g. media testing. Embryo twinning by blastocyst bisection (Mitalipov et al., 2002) may circumvent limitations set by the developmental clock; however, minimum pluripotent-cell number at the time of implantation (Morris et al., 2012) might be required for development to birth in humans too, rendering embryo twinning undesirable not only for clinical but also for research purposes.
Supplementary data
Supplementary data are available at http://humrep.oxfordjournals.org/.
